2024-03-05 07:30:03 ET
More on Baxter, DaVita, etc.
- Baxter International Inc. Is A Buy (Technical Analysis)
- Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
- Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns
- Baxter in discussions to sell kidney care unit, stock up 4%
- Outset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlook
Read the full article on Seeking Alpha
For further details see:
Novo Nordisk slips, dialysis stocks gain after kidney disease data for Ozempic